What is claimed is:
1. A semiconductor chip comprising a plurality of device elements, and a reference element located at a reference position of the semiconductor chip for fixing coordinates of one of said device elements with respect to coordinates of said reference element, said reference element emitting light andor generating heat upon energization thereof.
2. The semiconductor chip as defined in claim 1, wherein said reference element is connected to an external terminal.
3. The semiconductor chip as defined in claim 2, wherein said external terminal is a test terminal of an evaluation test circuit for evaluation of characteristics of the semiconductor chip.
4. The semiconductor chip as defined in claim 1, wherein said reference element is connected to an internal pad not connected to an external terminal.
5. The semiconductor chip as defined in claim 1, wherein said reference element emits lights andor generates heat substantially at a position specified by a single set of two-dimensional coordinates.
6. The semiconductor chip as defined in claim 1, wherein said reference element is disposed in a vicinity of each of two of four corners of the semiconductor chip.
7. The semiconductor chip as defined in claim 1, wherein said reference element is disposed in a vicinity of each of three of four corners of the semiconductor chip.
8. A method for identifying location of malfunction in a semiconductor device, comprising the steps of detecting a failed element in a test operation, energizing a reference element for light emission andor heat generation, and fixing coordinates of the failed element with respect to coordinates of the reference element.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A compound having the structure of Formula (I),
wherein
EDG is an electron donor group;
\u03c0CE is a pi-conjugation element; and
WSG is a water soluble group;
wherein
said electron donor group is R1-substituted or unsubstituted alkyl, R1-substituted or unsubstituted cycloalkyl, R1-substituted or unsubstituted heterocycloalkyl, R1-substituted or unsubstituted aryl, R1-substituted or unsubstituted heteroaryl, -NR4C(O)R3, -NR4R5, or -PR7R8,
wherein
R1 is halogen, -OR9, -NR10R11, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, or unsubstituted heteroaryl
R4 is hydrogen, R12-substituted alkyl, R12-substituted or unsubstituted heteroalkyl, R12-substituted or unsubstituted cycloalkyl, R12-substituted or unsubstituted heterocycloalkyl R12-substituted or unsubstituted aryl or R12-substituted or unsubstituted heteroaryl;
R3, R5, R6, R7 and R8 are independently hydrogen, R12-substituted or unsubstituted alkyl, R12-substituted or unsubstituted heteroalkyl, R12-substituted or unsubstituted cycloalkyl, R12-substituted or unsubstituted heterocycloalkyl, R12-substituted or unsubstituted aryl or R12-substituted or unsubstituted heteroaryl, wherein R4 and R5 are optionally joined together to form an R12-substituted or unsubstituted heterocycloalkyl, or R12-substituted or unsubstituted heteroaryl;
R9, R10 and R11 are independently hydrogen, R12-substituted or unsubstituted alkyl, R12-substituted or unsubstituted heteroalkyl, R12-substituted or unsubstituted cycloalkyl, R12-substituted or unsubstituted heterocycloalkyl, R12-substituted or unsubstituted aryl, or R12-substituted or unsubstituted heteroaryl, wherein R10 and R11 are optionally joined together to form an R12-substituted or unsubstituted heterocycloalkyl, or R12-substituted or unsubstituted heteroaryl
R12 is halogen, -OR13, -NR14R15, R16-substituted or unsubstituted alkyl, R16-substituted or unsubstituted heteroalkyl, R16-substituted or unsubstituted cycloalkyl, R16-substituted or unsubstituted heterocycloalkyl, R16-substituted or unsubstituted aryl, or R16-substituted or unsubstituted heteroaryl;
R13, R14 and R15 are independently hydrogen or unsubstituted alkyl; and
R16 is unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, or unsubstituted heteroaryl;
wherein
said pi-conjugation element has the formula:
-L1-(A1)q-L2-(A2)r-L3- or -L1-(A1)q-L4-A3-L2-(A2)r-L3-,
wherein
q and r are independently 0 or 1 and at least one of q or r is 1;
at least one of A1 or A2 is R17-substituted or unsubstituted
L1, L2, L3 and L4 are independently a bond or a linking group having the formula:
\u2003wherein x is an integer from 1 to 50;
A1, A2 and A3 are independently R17-substituted or unsubstituted arylene, or
R17-substituted or unsubstituted heteroarylene;
R17 is halogen, \u2014OR18, \u2014NR19R20, R21-substituted or unsubstituted alkyl, R21-substituted or unsubstituted heteroalkyl, R21-substituted or unsubstituted cycloalkyl, R21-substituted or unsubstituted heterocycloalkyl, R21-substituted or unsubstituted aryl, or R21-substituted or unsubstituted heteroaryl;
R18, R19 and R20 are independently hydrogen, R21-substituted or unsubstituted alkyl, R21-substituted or unsubstituted heteroalkyl, R21-substituted or unsubstituted cycloalkyl, R21-substituted or unsubstituted heterocycloalkyl, R21-substituted or unsubstituted aryl, or R21-substituted or unsubstituted heteroaryl;
R21 is halogen, \u2014OR22, \u2014NR23R24, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, or unsubstituted heteroaryl; and
R22, R23 and R24 are independently hydrogen or unsubstituted alkyl.
2. The compound according to claim 1, wherein x is an integer from 1 to 10.
3. The compound of claim 1 wherein said water soluble group is R25-substituted or unsubstituted alkyl, R25-substituted or unsubstituted heteroalkyl, R25-substituted or unsubstituted cycloalkyl, R25-substituted or unsubstituted heterocycloalkyl, R25-substituted or unsubstituted aryl, R25-substituted or unsubstituted heteroaryl;
wherein
R25 is halogen, \u2014OR26, \u2014NR27R28, R29-substituted or unsubstituted alkyl, R29-substituted or unsubstituted heteroalkyl, R29-substituted or unsubstituted cycloalkyl, R29-substituted or unsubstituted heterocycloalkyl, R29-substituted or unsubstituted aryl, or R29-substituted or unsubstituted heteroaryl;
R26, R27 and R28 are independently hydrogen, R29-substituted or unsubstituted alkyl, R29-substituted or unsubstituted heteroalkyl, R29-substituted or unsubstituted cycloalkyl, R29-substituted or unsubstituted heterocycloalkyl, R29-substituted or unsubstituted aryl, or R29-substituted or unsubstituted heteroaryl, wherein R27 and R28 are optionally joined together to form an R29-substituted or unsubstituted heterocycloalkyl, or R29-substituted or unsubstituted heteroaryl;
R29 is halogen, \u2014OR30, \u2014NR31R32, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, or unsubstituted heteroaryl; and
R30, R31 and R32 are independently hydrogen or unsubstituted alkyl.
4. The compound according to claim 3, wherein said water soluble group is
wherein y is an integer from 1 to 50.
5. The compound according to claim 4, wherein R29 is unsubstituted alkyl.
6. The compound according to any one of claim 1, 2, or 3, said compound having the structure:
7. The compound according to claim 1, wherein A1, A2 and A3 are independently 17 -substituted or unsubstituted phenylene, or R17-substituted or unsubstituted naphthylene.
8. A pharmaceutical composition comprising a compound according to any one of claim 1, 2, 6, or 7 and a pharmaceutically acceptable excipient.
9. A compound represented by the following structural formula:
or a pharmaceutically acceptable salt thereof.
10. A compound represented by the following structural formula:
or a pharmaceutically acceptable salt thereof,
wherein:
R4 and R5 are independently hydrogen, R12-substituted or unsubstituted alkyl, R12-substituted or unsubstituted heteroalkyl, R12-substituted or unsubstituted cycloalkyl, R12-substituted or unsubstituted heterocycloalkyl, R12-substituted or unsubstituted aryl or R12-substituted or unsubstituted heteroaryl, wherein R4 and R5 are optionally joined together to form an R12-substituted or unsubstituted heterocycloalkyl, or R12-substituted or unsubstituted heteroaryl;
R12 is halogen, \u2014OR13, \u2014NR14R15, R16-substituted or unsubstituted alkyl, R16-substituted or unsubstituted heteroalkyl, R16-substituted or unsubstituted cycloalkyl, R16-substituted or unsubstituted heterocycloalkyl, R16-substituted or unsubstituted aryl, or R16-substituted or unsubstituted heteroaryl;
R13, R14 and R15 are independently hydrogen or unsubstituted alkyl;
R16 is unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, or unsubstituted heteroaryl;
R17 is halogen, \u2014OR18, \u2014NR19R20, R21-substituted or unsubstituted alkyl, R21-substituted or unsubstituted heteroalkyl, R21-substituted or unsubstituted cycloalkyl, R21-substituted or unsubstituted heterocycloalkyl, R21-substituted or unsubstituted aryl, or R21-substituted or unsubstituted heteroaryl;
R18, R19 and R20 are independently hydrogen, R21-substituted or unsubstituted alkyl, R21-substituted or unsubstituted heteroalkyl, R21-substituted or unsubstituted cycloalkyl, R21-substituted or unsubstituted heterocycloalkyl, R21-substituted or unsubstituted aryl, or R21-substituted or unsubstituted heteroaryl;
R21 is halogen, \u2014OR22, \u2014NR23R24, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, or unsubstituted heteroaryl;
R22, R23 and R24 are independently hydrogen or unsubstituted alkyl;
R29 is halogen, \u2014OR30, \u2014NR31R32, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, or unsubstituted heteroaryl;
R30, R31 and R32 are independently hydrogen or unsubstituted alkyl;
y is an integer from 1 to 10; and
z is an integer from 0 to 6.
11. The compound according to claim 10, said compound having the structure:
or a pharmaceutically acceptable salt thereof.
12. The compound according to claim 10, wherein R4 and R5 are optionally joined together to form an R12-substituted or unsubstituted heterocycloalkyl.
13. The compound according to claim 12, wherein said R12-substituted or unsubstituted heterocycloalkyl is a substituted or unsubstituted piperidinyl.
14. The compound according to claim 13, wherein y is 2 and z is 0.
15. A pharmaceutical composition comprising a compound according to any one of claims 9-14 and a pharmaceutically acceptable excipient.